新西兰时隔两个月再出现确诊 澳洲随即叫停旅游气泡
新西兰一名56岁妇人感染新型冠状病毒,是当地两个月来的首宗确诊个案,该名妇人於12月30日回国,入住奥克兰检疫中心隔离2个星期,期间两次检测结果均呈阴性,之後她回家後出现病徵,检测後发现南非病毒株呈阳性反应。
当局表示,暂时未出现本地确诊个案,怀疑该名妇人是於检疫中心受到感染,澳洲已立即暂停与新西兰的旅游气泡。
澳洲批准辉瑞(PFE .US)与BioNTech的疫苗作紧急使用,预计疫苗将在2月下旬开始以每周8万剂速度派发。另外,由於阿斯利康的疫苗生产出现问题,预计3月澳洲取得的疫苗数量将较阿斯利康所承诺的为少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.